Sclerosis multiplex (SM): vizsgálatok itt: Egyesült Államok

In Egyesült Államok 186 Also abroad 506

186 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

No phaseTaking people
Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
Where
Bethesda
Életkor
1 hónap to 99 év
People
2400
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT00794352
No phaseTaking people
Kesimpta (Ofatumumab) Pregnancy Registry
Where
La Jolla
Életkor
18 év to 100 év
People
725
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05634967
2. fázisTaking people
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Where
Albuquerque, Ann Arbor, Atlanta, Aurora, Austin, Birmingham, Boston, Buffalo, Chapel Hill, Charlottesville, Chicago, Cleveland, Columbus, Draper, Honolulu, Kansas City, Knoxville, Madison, New York, Novi, Omaha, Philadelphia, Rockville, San Diego, Santa Rosa, Seattle, Shreveport, Tampa, Towson, Tucson, Worcester
Életkor
18 év to 80 év
People
100
Run by
Reunion Neuroscience Inc
See details and how to joinNCT07002034
3. fázisTaking people
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Where
Bradenton, Columbus, Cordova, Greenville, Kansas City, Livingston, Maitland, Milwaukee, Orlando, Pheonix, Raleigh, Roeland Park, San Antonio, Scottsdale, Sherman, St Louis, Tampa, West Hollywood
Életkor
18 év to 60 év
People
705 worldwide
Run by
Zenas BioPharma (USA), LLC
See details and how to joinNCT07067463 · EU 2025-524316-11-00
2. fázisTaking people
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
Where
Baltimore, Kansas City, New York
Életkor
18 év to 60 év
People
120
Run by
Johns Hopkins University
See details and how to joinNCT07497399
No phaseTaking people
Investigating the Impact of Treadmill-integrated Virtual Reality Training on Walking Outside the Clinic
Where
Atlanta
Életkor
18 év and over
People
10
Run by
Shepherd Center, Atlanta GA
See details and how to joinNCT07927439
No phaseNot yet taking people in Egyesült Államok
Non-invasive Brain Stimulation to Improve Memory in Multiple Sclerosis
Where
Richardson
Életkor
18 év to 64 év
People
80
Run by
The University of Texas at Dallas
See details and how to joinNCT07914257
3. fázisTaking people
Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis
Where
Boston
Életkor
25 év to 75 év
People
48
Run by
MGH Institute of Health Professions
See details and how to joinNCT06136728
2. fázisTaking people
Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)
Where
Buffalo
Életkor
55 év to 75 év
People
30
Run by
State University of New York at Buffalo
See details and how to joinNCT06463743
No phaseNot yet taking people in Egyesült Államok
Evaluating the Effect of the Zeen Mobility Device on Clinical Practicality, Safety, and Impact (Via Assessments of Walking, Standing Tolerance, Balance, Endurance, Effort, and Participation in Daily Tasks) in an Outpatient Rehabilitation Setting for Individuals With Mobility Impairments.
Where
Pomona
Életkor
18 év and over
People
20
Run by
Casa Colina Hospital and Centers for Healthcare
See details and how to joinNCT07923201
3. fázisTaking people
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Where
Albuquerque, Boca Raton, Boston, Bradenton, Clearwater, Columbus, Cordova, Fullerton, Greenville, Indianapolis, Kansas City, Maitland, Naples, New York, Oklahoma City, Phoenix, Rochester Hills, Roeland Park, San Antonio, Scottsdale, Sherman, St Louis, Tampa, Torrance, West Hollywood, Worcester
Életkor
18 év to 60 év
People
990 worldwide
Run by
Zenas BioPharma (USA), LLC
See details and how to joinNCT07299019 · EU 2025-524322-18-00
No phaseTaking people
Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study
Where
Gainesville
Életkor
18 év to 100 év
People
15
Run by
University of Florida
See details and how to joinNCT07376772
No phaseTaking people
HOBSCOTCH-MS-Efficacy Trial
Where
Lebanon
Életkor
20 év to 75 év
People
125
Run by
Dartmouth-Hitchcock Medical Center
See details and how to joinNCT06951919
No phaseTaking people
Understanding and Enhancing Human Health and Movement
Where
Cleveland
Életkor
18 év and over
People
75
Run by
Louis Stokes VA Medical Center
See details and how to joinNCT07738978
No phaseTaking people
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Where
Altamonte Springs, Amherst, Ann Arbor, Atlanta, Aurora, Austin, Avon, Baltimore, Basalt, Bethlehem, Billings, Birmingham, Boca Raton, Boston, Bridgewater, Burlington, Centerville, Charlotte, Charlottesville, Cherry Hill, Chicago, Cincinnati, Clearwater, Cleveland, Coeur d'Alene, Colorado Springs, Columbus, Cullman, Dallas, Denver, Detroit, Edinburg, Evanston, Farmington, Fort Collins, Franklin, Freehold, Fresno, Frisco, Gainesville, Gilbert, Glen Burnie, Golden Valley, Grand Junction, Greenfield, Hartford, Honolulu, Huntsville, Kirkland, Knoxville, Lake Success, Las Vegas, Lexington, Lincoln, Livingston, Louisville, Lubbock, Maitland, Miami, Milwaukee, Mobile, Morgantown, Mount Juliet, Naples, Nashville, Neenah, Neptune City, New Bern, Newport Beach, New York, Norfolk, Norman, Ogden, Omaha, Orange, Orlando, Owosso, Paramus, Pensacola, Phoenix, Plymouth, Portland, Raleigh, Rochester Hills, Roeland Park, Salem, Salt Lake City, San Antonio, Savannah, Scottsdale, Smyrna, Spring Hill, Teaneck, The Bronx, Toledo, Urbana, Vienna, Virginia Beach, Washington D.C., Waukesha, West Hollywood, Weston
Életkor
18 év and over
People
2000 worldwide
Run by
TG Therapeutics, Inc.
See details and how to joinNCT06433752
4. fázisTaking people
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Where
Atlanta, Birmingham, Cordova, Fort Collins, Maitland, Savannah, Scottsdale
Életkor
18 év to 65 év
People
100 worldwide
Run by
Genentech, Inc.
See details and how to joinNCT07609719
2. fázisTaking people
A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
Where
Atlanta, Columbus, Dallas, Oklahoma City, Raleigh, Stony Brook, Tampa
Életkor
18 év to 70 év
People
20
Run by
Sundance Biosciences, Inc.
See details and how to joinNCT07840326
No phaseTaking people
Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
Where
Bethesda
Életkor
2 év to 120 év
People
700
Run by
National Institute of Neurological Disorders and Stroke (NINDS)
See details and how to joinNCT01730131
No phaseTaking people
A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)
Where
Wilmington
Életkor
15 év to 50 év
People
728
Run by
TG Therapeutics, Inc.
See details and how to joinNCT06433765
2/3. fázisTaking people
Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis
Where
Salt Lake City
Életkor
10 év to 17 év
People
240 worldwide
Run by
TG Therapeutics, Inc.
See details and how to joinNCT07220252 · EU 2025-522257-19-00
No phaseTaking people
Dry Needling in Multiple Sclerosis
Where
Tampa
Életkor
18 év to 80 év
People
24
Run by
University of South Florida
See details and how to joinNCT07615725
2. fázisTaking people
Efgartigimod for the Treatment of Acute Optic Neuritis
Where
Boston
Életkor
18 év and over
People
20
Run by
Anastasia Vishnevetsky, MD, MPH
See details and how to joinNCT06453694
No phaseTaking people
iConquerMS™ - A Patient-Powered Research Network for Multiple Sclerosis
Where
Waltham
People
20 000
Run by
Accelerated Cure Project for Multiple Sclerosis
See details and how to joinNCT02486562
1. fázisTaking people
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
Where
Ann Arbor, Cleveland, Columbus, La Jolla, Milwaukee, New York, Omaha, Rochester
Életkor
18 év and over
People
100
Run by
TG Therapeutics, Inc.
See details and how to joinNCT06680037
2. fázisTaking people
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
Where
Aurora, Birmingham, Cincinnati, Columbus, Farmington, Foxborough, Kansas City, Kirkland, Knoxville, Lewisville, Naples, Philadelphia, Scottsdale, Southfield, St Louis, Tampa
Életkor
18 év to 70 év
People
200 worldwide
Run by
Celgene
See details and how to joinNCT06782490